Abstract 997P
Background
Microvascular invasion (MVI) is an independent poor factor for early recurrence (ER) and long-term outcomes in hepatocellular carcinoma (HCC) after hepatectomy. A practical, convenient, and accurate risk classifications is urgently needed to predict ER risk in HCC patients with MVI and to guide those patients to choose suitable adjuvant therapies to reduce postoperative recurrence risks and prolong long-term survival.
Methods
Data of 440 HCC patients with MVI after curative hepatectomy were retrospectively reviewed. They were randomly divided into a training set and a validation set. Kaplan-Meier curves and Cox regression analyses were used to identify independent prognostic factors of ER. Classification and regression tree (CART) analysis was used to develop ER risk classification in the training set and verified in the validation set.
Results
Multivariate analysis revealed that seven factors, namely, hepatitis B virus deoxyribonucleic acid load, tumor size, Edmondson-Steiner grade, MVI classification, satellite nodules, Ki67 positive index, and cytokeratin 19 expression were independent risk indexs for ER in HCC patients with MVI. The CART strategy showed a good concordance statistics of 0.77 in predicting ER risk, and had a better net benefit and a wider threshold probability range, as well as had a good agreement between the predicted value and actual observed value. The area under the time-dependent receiver operating characteristic curve of the CART strategy in predicting 1-, 3-, and 5-years recurrence-free survival (RFS) were 0.75, 0.78, and 0.84, respectively, and the corresponding overall survival (OS) were 0.74, 0.74, and 0.72, respectively, which were all significantly higher than other eight commonly classic HCC system stages (BCLC stage, Okuda stage, TNM stage, CNLC stage, French stage, CLIP score and JIS score). The ER, RFS and OS were greatly discrepancies between patients that had been stratified into three risk groups. Similar results were obtained in the validation set.
Conclusions
The CART strategy achieved optimal prediction for ER, RFS and OS for HCC patients with with MVI after curative hepatectomy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
This research was supported by the National Natural Science Foundation of China (NO. 82060427, 82103297), Guangxi Key Research and Development Plan (NO. GUIKEAB19245002), Guangxi Scholarship Fund of Guangxi Education Department, Guangxi Natural Science Foundation (NO. 2020GXNSFAA259080).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
842P - Multicenter real-world study of newly diagnosed advanced-stage extranodal natural killer/T cell lymphoma (ENKTL): Proposal for intensive therapy
Presenter: Yu-Ce Wei
Session: Poster session 18
844P - Progression -free survival prediction of multiple myeloma patients in five European countries using machine learning models
Presenter: Maria Luisa Pleguezuelo Witte
Session: Poster session 18
845P - A machine learning based clinical platform for cancer subtyping and data integration in hematological malignancies
Presenter: Michelle Tang
Session: Poster session 18
846P - Artificial intelligence-driven identification of onco-hematology patients who may develop severe COVID-19
Presenter: Souad Assaad
Session: Poster session 18
847P - Fatal infections among leukemia patients
Presenter: Huijie Zhou
Session: Poster session 18
848P - Mortality after rasburicase vs allopurinol anti-hyperuricemia monotherapy in patients with liquid tumors
Presenter: Mitchell Cairo
Session: Poster session 18
849P - Long non-coding RNA signatures and their role in the progression of childhood T cell acute lymphoblastic leukemia
Presenter: Pankaj Sharma
Session: Poster session 18
850P - A zebrafish model of MYC-driven acute myeloid leukemia reveals that neutrophil resistance to oncogenic transformation depends on their ability to promote PP2A-mediated MYC proteasomal degradation
Presenter: Anna Maria Luciano
Session: Poster session 18
851P - Characterization of a zebrafish model of MYC-driven acute myeloid leukemia
Presenter: Anna Maria Luciano
Session: Poster session 18
852P - c-MAF-driven metabolic reprogramming mediates H3K27 hyperacetylation to regulate super enhancer-associated genes
Presenter: Phyllis SY Chong
Session: Poster session 18